Definitive Contract HT942523C0044

Award Date 7/14/23
Potential Completion Date 11/13/25
Potential Value $1.1M
Awardee
Giner Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Auburndale, MA 02466, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
STTR Phase II
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price STTR Phase I contract awarded by the Medical Command (MEDCOM) of the U.S. Army to Giner Inc., a Boston-based research and development firm, for the project "RAPID AND REPROGRAMMABLE ASSAY FOR MULTIPLEXED GENE DETECTION". The contract, with a ceiling value of $166,430.81, was awarded on April 12, 2020 and has a completion date of February 11, 2022. The contract is set aside for small businesses. Giner Inc. is a Subchapter S Corporation that has extensive...
This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the U.S. Army Research, Development and Engineering Command (RDECOM) to Giner Inc., a Boston-based research and development firm. The contract has a value of $995,662.27 and a completion date of August 5, 2020. Giner Inc. is a small business that has received numerous federal contracts and grants from agencies such as NASA, the Department of Defense, and the Department of Energy, to develop advanced technologies...
This federal contract award, valued at $149,820.09, was issued by the U.S. Army Research, Development and Engineering Command (RDECOM) to Giner Inc., a Boston-based small business focused on developing and commercializing electrochemical technologies. The contract is a Phase I SBIR (Small Business Innovation Research) award, indicating it supports early-stage research and development. The contract type is a firm-fixed-price purchase order, with an ultimate completion date of April 5, 2017. Giner...
This contract is an SBIR Phase I award from the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Giner Inc., a Boston-based research and development firm. The contract, valued at $149,983.00, is for a Small Business Innovation Research (SBIR) project and does not have a set-aside designation. Giner Inc. is a for-profit, subchapter S corporation that specializes in developing cutting-edge electrochemical technologies, including those for clean energy,...
This is a federal contract award from the Centers for Disease Control and Prevention (CDC) to Giner Inc., a research and development firm based in Massachusetts. The contract, valued at $149,992.02, is for "critical functions" and has a set-aside designation for small businesses. The contract is a firm fixed-price purchase order with a completion date of May 22, 2017. Giner Inc. is a technology company that has previously secured contracts and grants from various federal agencies,...
This is a SBIR Phase II contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Giner Inc., a Boston-based research and development firm. The $999,518.00 cost-plus-fixed-fee contract has a completion date of March 4, 2020 and does not have a set-aside designation. Giner Inc. is a for-profit subchapter S corporation that has received numerous federal contracts and grants from agencies like NASA, the Department of Defense, the Department of...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian agency, to Giner Inc., a small business research and development firm based in Auburndale, Massachusetts. The $299,749 firm-fixed-price contract is for biomedical research and development work. Giner Inc. has a history of securing federal contracts and grants from agencies like NASA, the Department of Defense, and the Department of Energy to develop advanced...
The Department of Health and Human Services National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases awarded a Cost Plus Fixed Fee definitive contract to Giner Inc., a Boston-based research and development firm, for RESEARCH AND DEVELOPMENT FACILITIES. The contract has a potential value of $1,500,000.00 and does not have a set-aside designation. Giner Inc. is a for-profit Subchapter S Corporation that has extensive experience in developing cutting-edge...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of the Navy Naval Sea Systems Command to Giner Inc., a research and development firm based in Boston, Massachusetts. The firm-fixed-price contract, valued at $239,633.00, is for the delivery of kickoff briefing materials and a Facility Workforce Agreement (FWA) certification. As an SBIR contract, this award is set aside for small businesses. Giner Inc. is a for-profit Subchapter S corporation that...
This is a $750,000.00 firm fixed price Purchase Order issued by the Air Force Research Laboratory (AFRL) to Giner Inc., a Boston-based research and development firm, under the Small Business Innovation Research (SBIR) Program. The contract is for the development of lithium-sulfur batteries for Air Force applications, with a completion date of September 12, 2024. Giner Inc. has a history of Federal contracting, having received awards from agencies such as NASA, the Department of Defense, and...

This is a $1,099,888.52 Firm Fixed Price definitive contract awarded by the Defense Health Agency (DHA) to Giner Inc., a Boston-based research and development firm focused on electrochemical technologies. The contract is for a STTR Phase II effort titled "Rapid and Reprogrammable Assay for Multiplexed Gene Detection." This Small Business set-aside contract supports the DHA's medical research and development mission, with an ultimate completion date of November 13, 2025. Giner Inc. has extensive experience delivering research, prototypes, and products to government agencies including NASA, the Department of Defense, and the Department of Energy through both contracts and grants. The company's portfolio includes advanced batteries, fuel cells, sensors, water treatment technologies, and other tools to support public health, medical research, environmental monitoring, and clean energy applications.

Generated 7/16/24, 12:44 PM